
|Articles|June 1, 2008
- Volume 0 0
NYCOMED MERGES WITH BRADLEY PHARMACEUTICALS
Advertisement
Nycomed US Inc recently completed its acquisition of Bradley Pharmaceuticals, a company focused on niche therapeutic markets in the United Sates. Nycomed will expand the line of dermatology products currently offered through its PharmaDerm Division. The company also expects that the purchase will provide an enhanced platform for in-licensing and copromotion of dermatology products.
Articles in this issue
about 18 years ago
can you READ these Rxs?about 18 years ago
Case Studiesabout 18 years ago
ASTHMA WATCHabout 18 years ago
CHOLESTEROL WATCHabout 18 years ago
ARTHRITIS WATCHabout 18 years ago
WOMEN'S HEALTH WATCHabout 18 years ago
DIABETES WATCHabout 18 years ago
compounding HOTLINEabout 18 years ago
pharmacy TECHNOLOGY newsabout 18 years ago
pharmacy TECHNOLOGY productsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































